Prostate Cancer - Results from #23520

Prostate cancer screening in men ages 75 and older fell by 8 percentage points after task force recommendation - Abstract April 8, 2013

Two innovative pharmaceutical forms of leuprorelin: Results from 818 patients with advanced prostate cancer - Abstract April 8, 2013

When the tumour is not the culprit: Avascular necrosis of the hip in a patient with castration-resistant prostate cancer - Abstract April 5, 2013

Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer - Abstract April 5, 2013

Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy - Abstract April 5, 2013

First report of transperineal polyethylene glycol hydrogel spacer use to curtail rectal radiation dose after permanent iodine-125 prostate brachytherapy - Abstract April 5, 2013

Differences in survival from prostate cancer in Denmark, Iceland and Sweden - Abstract April 5, 2013

Systematic review of hypofractionated radiation therapy for prostate cancer - Abstract April 5, 2013

Impact of applied progressive deep muscle relaxation training on the health related quality of life among prostate cancer patients - A quasi experimental trial - Abstract April 5, 2013

The prevalence and severity of fatigue in men with prostate cancer: A systematic review of the literature - Abstract April 5, 2013

GU Cancers Symposium 2013 - Updated interim analysis (55% OS) of COU-AA-302, a randomized phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy - Slide Lecture April 5, 2013

On-and-off approach to prostate cancer treatment may compromise survival April 4, 2013

Enzalutamide for the treatment of prostate cancer - Abstract April 4, 2013

A case of hepatitis C virus possible transmission following a transrectal ultrasound guided prostate biopsy - Abstract April 4, 2013

How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate cancer? - Abstract April 4, 2013

Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: Longitudinal follow-up from a prospective trial - Abstract April 4, 2013

Upgrading of Gleason score and prostate volume: A clinicopathological analysis - Abstract April 4, 2013

Long-term follow-up of a phase II trial of chemotherapy plus hormone therapy for biochemical relapse after definitive local therapy for prostate cancer - Abstract April 4, 2013

Advances in the multimodality management of high-risk prostate cancer - Abstract April 4, 2013

Timing of curative treatment for prostate cancer: A systematic review - Abstract April 4, 2013

Page 1177 of 1437